BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 25308020)

  • 61. Neoplasms in the trocar site and peritoneal papillary serous cystadenocarcinoma.
    Lai CR; Yen MS; Wang PH
    Taiwan J Obstet Gynecol; 2014 Jun; 53(2):139-40. PubMed ID: 25017255
    [No Abstract]   [Full Text] [Related]  

  • 62. A Paratesticular Serous Borderline Tumor in a Pediatric Patient With Proteus Syndrome.
    Klaassen Z; Fox PJ; McLees L; Zheng M; Sharma S; Donohoe JM; Neal DE
    Urology; 2015 Dec; 86(6):1218-21. PubMed ID: 26368507
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Ovarian type surface epithelial carcinoma of the testis with delayed metastatic spread.
    Maruschke M; Schmidt W; Casper J; Hakenberg OW
    Urol Int; 2008; 81(1):119-21. PubMed ID: 18645284
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The prognostic significance of thrombocytosis in uterine papillary serous carcinomas.
    Lerner DL; Walsh CS; Cass I; Karlan BY; Li AJ
    Gynecol Oncol; 2007 Jan; 104(1):91-4. PubMed ID: 16934317
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Ovarian serous surface papillary borderline tumors form sea anemone-like masses.
    Tanaka YO; Okada S; Satoh T; Matsumoto K; Oki A; Nishida M; Yoshikawa H; Saida T; Minami M
    J Magn Reson Imaging; 2011 Mar; 33(3):633-40. PubMed ID: 21287653
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Leiomyosarcoma arising from tunica vaginalis testis: a case report.
    Bajaj P; Agarwal K; Niveditha SR; Pathania OP
    Indian J Pathol Microbiol; 2001 Apr; 44(2):145-6. PubMed ID: 11883131
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Papillary serous adenocarcinoma of the ovary diagnosed after malignant pericardial tamponade and embolic stroke.
    Winter WE; Seidman J; Krivak TC; Pujari SG; Boice CR; Carlson JW
    Gynecol Oncol; 2002 Mar; 84(3):453-5. PubMed ID: 11855887
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Analysis of cytogenetic alterations in stage III serous ovarian adenocarcinoma reveals a heterogeneous group regarding survival, surgical outcome, and substage.
    Partheen K; Levan K; Osterberg L; Helou K; Horvath G
    Genes Chromosomes Cancer; 2004 Aug; 40(4):342-8. PubMed ID: 15188458
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Well-differentiated serous neoplasms of the ovary.
    Longacre TA; Kempson RL; Hendrickson MR
    Pathology (Phila); 1993; 1(2):255-306. PubMed ID: 9420921
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Normal-sized ovary carcinoma syndrome--clinical and pathological analysis of 11 cases].
    Yao Z; Li L; Yang H
    Zhonghua Zhong Liu Za Zhi; 1998 Sep; 20(5):383-6. PubMed ID: 10921039
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Prognosis of stage III or IV primary peritoneal serous papillary carcinoma.
    Dubernard G; Morice P; Rey A; Camatte S; Fourchotte V; Thoury A; Pomel C; Pautier P; Lhommé C; Duvillard P; Castaigne D
    Eur J Surg Oncol; 2004 Nov; 30(9):976-81. PubMed ID: 15498644
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Serous papillary cancer of the peritoneum: a multicentric primary disease].
    Maassen V; Debus-Thiede G
    Zentralbl Gynakol; 1993; 115(8):347-54. PubMed ID: 8212940
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Uterine papillary serous carcinoma: what have we learned over the past quarter century?
    Goff BA
    Gynecol Oncol; 2005 Sep; 98(3):341-3. PubMed ID: 16111527
    [No Abstract]   [Full Text] [Related]  

  • 74. [Paratesticular sarcomas. Case report of leiomyosarcoma].
    Gerber S; Futterlieb A; Schmid HP; Weimann R; Glättli A
    Chirurg; 2000 Aug; 71(8):966-8. PubMed ID: 11013819
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Papillary cystadenocarcinoma arising from minor salivary glands in the anterior portion of the tongue: a case report.
    Nakagawa T; Hattori K; Iwata N; Tsujimura T
    Auris Nasus Larynx; 2002 Jan; 29(1):87-90. PubMed ID: 11772498
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Papillary cystadenoma: a rare differential diagnosis of a paratesticular tumour].
    Dräger DL; Zonnur S; Erbersdobler A; Protzel C; Hakenberg OW
    Aktuelle Urol; 2018 Jun; 49(3):262-265. PubMed ID: 28511230
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Testicular/paratesticular mesothelial tumours: Uncommon histopathologic entities in a very complex anatomical site.
    Pagliuca F; Lucà S; De Sio M; Arcaniolo D; Facchini G; De Martino M; Esposito F; DE Vita F; Chieffi P; Franco R
    Pathol Res Pract; 2024 Jan; 253():155069. PubMed ID: 38181581
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Paratesticular endometrioid adenocarcinoma of the ovarian surface epithelial type with neuroendocrine differentiation: an undescribed entity.
    Mundada A; Kakkar A; Menon S
    Histopathology; 2022 Jan; 80(2):443-445. PubMed ID: 34245593
    [No Abstract]   [Full Text] [Related]  

  • 79. Paratesticular papillary mesothelioma.
    Linn R; Moskovitz B; Bolkier M; Munichor M; Levin DR
    Urol Int; 1988; 43(1):60-1. PubMed ID: 3376366
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Possible association between BRCA-1 carriers and incidence of uterine papillary serous carcinoma (UPSC).
    Lavie O; Ben-Arie A; Gemer O
    Int J Gynecol Cancer; 2008; 18(5):1150. PubMed ID: 17986237
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.